Transpire Bio Announces Completion of First Human Dosing in Clinical Trial Using its Novel Inhalation Formulation

SUNRISE, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) — Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has successfully dosed the first human subject with its experimental drug candidate in a novel inhalation formulation.  The initial clinical study is designed to evaluate pulmonary […]